Financial

Caris Life Sciences Announces a Strategic Collaboration with Ontada® to Advance Oncology Research and the Adoption of Precision Medicine

The collaboration brings together Caris' extensive genomic data and molecular expertise with Ontada's robust clinical data and research capabilities to...

Artificial Intelligence (AI) in Medical Imaging Market to Hit USD 4.54 Billion by 2029 with 22.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 15, 2025 /PRNewswire/ -- The global AI medical imaging market, valued at US$ 1.29 billion in 2023,...

Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, and Treatment

Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapySAN FRANCISCO--(BUSINESS WIRE)--#aihealthcare--Viz.ai, the leader in...

Century Health Announces Partnership with Nira Medical to Deliver AI Curated EHR Data for More Than 3,000 Multiple Sclerosis Patients

Century Health's AI platform integrates with EHRs to unlock valuable clinical data that has been historically messy, unstructured and inaccessibleNira...

Century Health Announces Partnership with Nira Medical to Deliver AI Curated EHR Data for More Than 3,000 Multiple Sclerosis Patients

Century Health's AI platform integrates with EHRs to unlock valuable clinical data that has been historically messy, unstructured and inaccessibleNira...

MedPro Group Endorses Surgical Safety Technologies’ OR Black Box® as Ground-breaking Technology to Improve Surgical Quality and Safety

FORT WAYNE, Ind. and NEW YORK, Jan. 14, 2025 /PRNewswire/ -- MedPro Group, a Berkshire Hathaway company and the nation's leading...

MedPro Group Endorses Surgical Safety Technologies’ OR Black Box® as Ground-breaking Technology to Improve Surgical Quality and Safety

FORT WAYNE, Ind. and NEW YORK, Jan. 14, 2025 /PRNewswire/ -- MedPro Group, a Berkshire Hathaway company and the nation's leading...

The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease

Partnership Will Harness NYSCF's Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level NEW...

error: Content is protected !!